fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Abbott India Ltd

Abbott India Ltd

Updated on July 28, 2020

Stock/Share Code - ABBOTINDIA

Abbott India is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.(Source : 201903 Annual Report Page No: 58)

Below is the details of ABBOTINDIA Abbott India Ltd

Market Cap₹35,537 Cr.
Current Price ₹16,009.1 as on 3 Aug 20
52 Week High / Low Price₹18,679.75 / ₹7,711.2
Face Value₹10
Stock P/E59.71
Book Value₹1,004
Dividend Yield0.30 %
ROCE37.36 %
ROE24.00 %
Sales Growth (3yrs)12.06 %
SectorPharmaceuticals
IndustryPharmaceuticals - Multinational
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 30.18%
Cons: Stock is trading at 16.67 times its book value The company has delivered a poor growth of 10.08% over past five years.

Abbott India Ltd Price Chart

Abbott India Ltd Price Chart

Abbott India Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Abbott India ₹263.6 59.71 ₹35,537.23 Cr. 0.30 ₹186.69 Cr. 59.50 13.78 1078.25 37.36
2. Glaxosmi. Pharma ₹41.6 55.82 ₹23,197.62 Cr. 1.46 ₹138.07 Cr. -2.34 3.33 775.80 31.11
3. Pfizer ₹4,398.25 35.83 ₹18,475.68 Cr. 0.56 ₹139.06 Cr. 5.40 4.75 538.18 23.22
4. Sanofi India ₹8,298.35 37.29 ₹17,808.18 Cr. 1.37 ₹85.4 Cr. 24.62 9.37 784.50 28.84
5. Astrazeneca Phar ₹3,390.4 105.68 ₹7,632.5 Cr. 0.03 ₹9.58 Cr. -2.44 2.42 194.90 26.51
6. Proc. Gam. Heal. ₹111.25 41.48 ₹6,823.18 Cr. 0.58 ₹46.46 Cr. 14.12 -1.26 228.11 78.16
7. Novartis India ₹263.6 62.00 ₹1,415.4 Cr. 1.74 ₹7.73 Cr. -39.94 -13.39 117.46 7.58

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Abbott India Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019
Sales -7066989318817888459809489069991,0551,078
YOY Sales Growth %3.19%-4.33%29.10%18.08%11.72%21.10%5.24%7.51%14.96%18.22%7.66%13.78%
Expenses -643644730718682734786801753825851839
Material Cost %60%63%56%58%55%56%57%58%56%56%57%55%
Employee Cost %12%14%11%10%14%14%11%11%12%12%11%11%
Operating Profit6353201163107111194146153174204240
OPM %9%8%22%19%14%13%20%15%17%17%19%22%
Other Income152415195922253829302928
Interest211121101222
Depreciation444444445151515
Profit before tax7273212178159129214180177187216251
Tax %42%34%35%35%37%36%36%35%36%37%18%25%
Net Profit424813811510082138117113117178187
EPS in Rs19.7922.7164.7254.3047.1038.7864.7955.0853.2855.0383.9287.85
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Nov 2007Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales -5946667619901,4901,6532,2762,2892,6142,9033,2983,6794,038
Sales Growth %16.48%12.06%14.25%30.09%50.54%10.90%37.71%0.59%14.20%11.02%13.64%11.52%
Expenses -5135906639201,3151,4702,0091,9772,2502,5052,7743,0743,267
Material Cost %69%68%66%65%58%59%57%57%57%59%58%57%
Manufacturing Cost %1%2%2%2%1%1%1%1%1%1%1%1%
Employee Cost %6%7%8%11%11%12%13%13%13%12%12%12%
Other Cost %10%11%11%15%18%17%17%15%15%15%13%14%
Operating Profit82769770176183267312365398525605771
OPM %14%11%13%7%12%11%12%14%14%14%16%16%19%
Other Income26262936205149485057117113116
Interest0000000032426
Depreciation67911151922151416161750
Profit before tax1029411794180215295344398436621699830
Tax %33%33%34%35%33%33%33%34%36%37%35%36%
Net Profit68637861120145198229255277401450595
EPS in Rs43.9443.5853.7738.5253.9065.3471.59101.44120.12130.19188.81211.93280.08
Dividend Payout %37%30%30%38%30%25%25%29%29%31%29%31%

Compounded Sales Growth

  • 10 Years:: 18.64%
  • 5 Years:: 10.08%
  • 3 Years:: 12.06%
  • TTM:: 13.41%

Compounded Profit Growth

  • 10 Years:: 22.05%
  • 5 Years:: 18.43%
  • 3 Years:: 20.25%
  • TTM:: 36.12%

Return on Equity

  • 10 Years:: 31.81%
  • 5 Years:: 33.27%
  • 3 Years:: 58.84%
  • 1 Year:: 115.02%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Nov 2007Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital -14141414212121212121212121
Equity Capital14.4713.6813.6813.6821.2521.2521.2521.2521.2521.2521.2521.25
Reserves2172082582925236267679161,1741,3661,6721,9872,111
Borrowings11000000000051
Other Liabilities -98129117148253260351436421679723932993
Trade Payables31714358121101136194230475481664700
Advance from Customers000011100225
Other liability items67577390131158214242191202240263292
Total Liabilities3303513884537979071,1391,3741,6162,0662,4162,9413,176
Fixed Assets -3548495080109989610811081105149
Gross Block8099107118192204209216123140124165
Accumulated Depreciation455158681129511112014304360
CWIP1301011436211
Investments150000000000000
Other Assets -1443003394037177981,0401,2741,5051,9502,3332,8353,027
Inventories8692102129255264359384370501585607627
Trade receivables30324465133141109129145176263276308
Cash Equivalents171641761892593234636448391,0911,0311,6841,813
Loans n Advances121419245057788411514741222163
Other asset items-1-2-3-42113303235354147215
Total Assets3303513884537979071,1391,3741,6162,0662,4162,9413,176

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Nov 2007Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity -3187374624101155215249307153499
Profit from operations9692122101182206293307374399545621
Receivables-5-5-13-23-52-1127-22-16-34-88-13
Inventory-32-6-10-26-73-9-103-2514-131-85-21
Payables442-244343-173556392475186
Loans Advances0000-15-8-5-10-16-23-27
Direct taxes-33-36-38-49-60-65-110-116-147-159-205-257
Other operating items0000051716-16-0410
Cash from Investing Activity -57140-1-1656-59-144-187-77-155-215-257
Fixed assets purchased-11-21-8-12-16-17-18-18-23-21-24-12
Fixed assets sold200000143005217
Investments purchased-98-2400-00000000
Investments sold16318000370000000
Interest received06661523324050556393
Dividends received000010000000
Inter corporate deposits000000000-189-105-554
Other investing items001-1019-65-172-211-105-1-200200
Cash from Financing Activity --83-81-23-27-42-42-42-58-80-90-102-143
Repayment of borrowings-0-0-1000000000
Interest paid fin-0-0-0-0-0-0-0-0-1-0-0-2
Dividends paid-30-30-22-27-42-42-42-49-66-74-85-117
Other financing items-53-5100000-9-13-15-17-24
Net Cash Flow4146133381-31-309162-16599

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Nov 2007Nov 2008Nov 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %41%40%48%33%42%34%39%40%38%34%41%37%
Debtor Days191821243231182120222927
Inventory Turnover8.427.467.828.577.776.377.316.166.936.676.076.17

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Abbott India Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.